Apr 04, 2024 9:31am EDT FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
Mar 28, 2024 9:31am EDT FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Mar 19, 2024 9:31am EDT FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
Feb 20, 2024 9:31am EST FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
Feb 13, 2024 9:31am EST FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
Feb 08, 2024 9:31am EST FibroBiologics Announces Three United States Patents for Fibroblast Technology